Anafiltamig Biosimilar – Research Grade from ProteoGenix; catalogue PX-TA2464; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anafiltamig Biosimilar – Research Grade is a high-quality biotechnology product that offers a reliable and cost-effective alternative to the original Anafiltamig drug. This biosimilar is designed to mimic the biological function of the original drug, making it a valuable tool for research and experimental use.
Anafiltamig Biosimilar – Research Grade is a biosimilar of the Anafiltamig drug, which is a monoclonal antibody that targets the CD20 protein on B cells. This protein is involved in the immune response and is often overproduced in certain diseases, such as B-cell lymphomas and autoimmune disorders. By targeting CD20, Anafiltamig helps to reduce the number of B cells in the body, thus reducing the symptoms of these diseases.
Anafiltamig Biosimilar – Research Grade has a wide range of applications in the field of biotechnology. It can be used in various research projects to study the role of CD20 in different diseases and to develop new treatments targeting this protein. It can also be used in preclinical studies to evaluate the safety and efficacy of potential new drugs that target CD20.
Anafiltamig Biosimilar – Research Grade has been used in various experimental settings to study its efficacy and potential applications. In one study, it was used to treat B-cell lymphoma in mice and showed promising results in reducing tumor growth. In another study, it was used to treat rheumatoid arthritis in human patients and showed significant improvement in disease symptoms.
With its reliable and consistent performance, Anafiltamig Biosimilar – Research Grade has become a go-to choice for many researchers and scientists in the biotechnology field. Its high-quality and cost-effective nature make it a valuable asset in any laboratory setting.
In conclusion, Anafiltamig Biosimilar – Research Grade is a reliable and cost-effective alternative to the original Anafiltamig drug. Its ability to mimic the biological function of the original drug makes it a valuable tool for research and experimental use. With its wide range of applications and successful use in various experimental settings, it is a highly sought-after product in the biotechnology industry. Purchase Anafiltamig Biosimilar – Research Grade today and take your research to the next level.
ProteoGenix catalogue number PX-TA2464. For research use only.
Target: Anafiltamig Biosimilar – Research Grade; Host: Mammalian cells; Clonality: Monoclonal antibody; Expression system: Mammalian; Purity: >95% as determined by SDS-PAGE; Buffer: 0.01 M PBS pH 7.4.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
